✦ LIBER ✦

A dose-dense schedule of docetaxel followed by doxorubicin and cyclophosphamide as neoadjuvant treatment for breast cancer: results from a phase II study

✍ Scribed by Silvia Antolín; Ramón Mel; Manuel Ramos; Andrés García-Palomo; Concepción Almanza; Laura de Paz; Lourdes Calvo; Elena Álvarez; Ana González; Jesús García-Mata

Publisher: Springer Milan
Year: 2011
Tongue: Spanish
Weight: 118 KB
Volume: 13
Category: Article
ISSN: 1699-048X
DOI: 10.1007/s12094-011-0715-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Doxorubicin and cyclophosphamide followe

Doxorubicin and cyclophosphamide followed by weekly docetaxel as neoadjuvant treatment of early breast cancer: analysis of biological markers in a GEICAM phase II study

✍ Laura G. Estevez; José Luis Fortes; Encarna Adrover; Gloria Peiró; Mireia Margel 📂 Article 📅 2009 🏛 Springer Milan 🌐 Spanish ⚖ 244 KB

Biweekly docetaxel and gemcitabine as ne

Biweekly docetaxel and gemcitabine as neoadjuvant chemotherapy followed by adjuvant doxorubicin and cyclophosphamide therapy in stage II and III breast cancer patients: results of a phase II study

✍ L. G. Estévez; P. Sánchez-Rovira; M. Dómine; A. León; I. Calvo; A. Jaén; V. Casa 📂 Article 📅 2007 🏛 Springer Milan 🌐 Spanish ⚖ 80 KB

Prospective phase II study of neoadjuvan

Prospective phase II study of neoadjuvant doxorubicin followed by cisplatin/docetaxel in locally advanced breast cancer

✍ Taher A. Al-Tweigeri; Dahish S. Ajarim; Adher A. Alsayed; Mohamed M. Rahal; Moha 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 272 KB

Phase II study of dose-dense sequential

Phase II study of dose-dense sequential doxorubicin and docetaxel for patients with advanced operable and inoperable breast cancer

✍ Brenda W. Cooper; Tomas Radivoyevitch; Beth A. Overmoyer; Robert R. Shenk; Huong 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 208 KB

Phase II study of dose-dense doxorubicin

Phase II study of dose-dense doxorubicin and docetaxel as neoadjuvant chemotherapy with G-CSF support in patients with large or locally advanced breast cancer

✍ Jesús García-Mata; Andrés García-Palomo; Lourdes Calvo; Ramón Mel; Juan Jesús Cr 📂 Article 📅 2008 🏛 Springer Milan 🌐 Spanish ⚖ 240 KB

Phase 2 study of neoadjuvant treatment w

Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II–IIIc breast cancer

✍ A. J. Montero; C. M. Diaz-Montero; Y. E. Deutsch; J. Hurley; L. G. Koniaris; T. 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 398 KB